1. Home
  2. NCZ vs CADL Comparison

NCZ vs CADL Comparison

Compare NCZ & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virtus Convertible & Income Fund II of Beneficial Interest

NCZ

Virtus Convertible & Income Fund II of Beneficial Interest

HOLD

Current Price

$15.24

Market Cap

288.7M

Sector

Finance

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$11.22

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCZ
CADL
Founded
2003
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
288.7M
1.0B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NCZ
CADL
Price
$15.24
$11.22
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$19.00
AVG Volume (30 Days)
39.7K
1.1M
Earning Date
01-01-0001
05-14-2026
Dividend Yield
12.16%
N/A
EPS Growth
N/A
58.62
EPS
N/A
N/A
Revenue
N/A
$125,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.95
$4.35
52 Week High
$16.17
$14.00

Technical Indicators

Market Signals
Indicator
NCZ
CADL
Relative Strength Index (RSI) 49.97 46.08
Support Level $14.88 $9.40
Resistance Level $15.84 $11.36
Average True Range (ATR) 0.30 0.70
MACD -0.02 -0.23
Stochastic Oscillator 62.62 39.10

Price Performance

Historical Comparison
NCZ
CADL

About NCZ Virtus Convertible & Income Fund II of Beneficial Interest

Virtus Convertible & Income Fund II is a diversified, closed-end management investment company. The investment objective of the company is to provide total return through a combination of current income, current gains and long-term capital appreciation. Its portfolio of investments includes different sector investments such as in healthcare services, media, oil, gas, and consumable fuels and others.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: